ストックスクリーナーアプリを入手
17.75
1.43%
0.25
前日終値:
$17.50
開ける：
$17.41
24時間の取引高:
21,736
Relative Volume:
0.31
時価総額：
$N/A
収益：
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
+2.72%
1か月 パフォーマンス:
+9.43%
6か月 パフォーマンス:
-33.09%
1年 パフォーマンス:
-36.18%
1日の値動き範囲:
$17.41
$17.89
1週間の範囲:
$16.85
$18.39
52週間の値動き範囲:
$13.42
$31.65
Virtus Lifesci Biotech Clinical Trials Etf Stock (BBC) Company Profile
BBC を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
BBC
Virtus Lifesci Biotech Clinical Trials Etf
|
17.75 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
292.58 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
594.20 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
597.04 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
234.74 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
521.51 | 124.43B | 0 | 0 | 0 | 0.00 |
Virtus Lifesci Biotech Clinical Trials Etf (BBC) 最新ニュース
Learn to Evaluate (BBC) using the Charts - news.stocktradersdaily.com
Vinay Prasad's Appointment To FDA's CBER Triggers Questions Over Future Of Cell And Gene Therapy Regulation - Benzinga
ETFs Last Week: Funds Lead The Charge As Markets Stage A Return To Risk-On - Benzinga
Tech Rally Boosted Wall Street Last Week: Winning ETFs in Focus - TradingView
6 Best-Performing ETFs of Last Week - TradingView
(BBC) Investment Analysis and Advice - news.stocktradersdaily.com
Wall Street Week Ahead - Seeking Alpha
(BBC) Technical Data - news.stocktradersdaily.com
Trend Tracker for (BBC) - news.stocktradersdaily.com
7 Best-Performing Biotech ETFs for March 2025 - NerdWallet
(BBC) Trading Signals - Stock Traders Daily
(BBC) Trading Advice - Stock Traders Daily
(BBC) Proactive Strategies - Stock Traders Daily
Stock Market Movers Today • Top Gainers & Losers - Benzinga
When (BBC) Moves Investors should Listen - Stock Traders Daily
(BBC) Long Term Investment Analysis - Stock Traders Daily
How to Take Advantage of moves in (BBC) - Stock Traders Daily
(BBC) Pivots Trading Plans and Risk Controls - Stock Traders Daily
Capitulation in biotech is near, as well as a rally – Piper Sandler (NYSEARCA:XBI) - Seeking Alpha
The Great Rotation: Just Getting Started? - ETF Trends
5 Top ETFs of Last Week - Nasdaq
SBIO, XBI, or BBP: Which is the Best Biotech ETF, According to Analysts? - TipRanks
9 Best Biotech ETFs for 2024 - MSN
The 5 Best Biotech ETFs of 2024 - ETF.com
5 Best ETF Areas of Last Week - Nasdaq
This biotech ETF sees ‘breakout’ while U.S. small-cap technology stocks lag - MarketWatch
Top and Flop Industry ETFs of Q3 - Nasdaq
ETFs to Play Biden's 2024 Reelection Campaign Launch - Nasdaq
ALPS’ Biotech ETF SBIO Week’s Top Performer - Nasdaq
Innovation Reigns In 10 Best-Performing ETFs Of The Last 3 Months - Financial Advisor (Mag)
Biotech ETFs Advance on Speculation of a Takeover Bid for Global Blood Therapeutics - ETF Trends
5 ETFs Riding High on the Biotech Comeback - Yahoo Finance
Biotech ETFs Are Making a Comeback - ETF Trends
Best Performing ETFs For June 2022 - TheStreet
Biotech ETF Tops in June: 5 Stocks That Outperform - Yahoo Finance
Betting on Biotech Bear Market Expiration Date - ETF Trends
Best & Worst Performing ETFs Of 2022 - Yahoo Finance
Positioning for Biotech Bounceback - ETF Trends
Biotech ETFs That Outperformed Last Week - Yahoo Finance
ETF Exchange: Latest ETF News & Insights | Pensions & Investments - Pensions & Investments
Biotech Ready to Participate in Healthcare Bullishness - Nasdaq
Drug Price Debate Might Not Hinder Biotech ETFs - ETFdb.com
Size Up SBIO Ahead of Biotech Rebound - ETF Trends
Finding Synergy With SPY - etf.com
Healthcare ETFs Surge on FDA Full-Vaccine Nod & Deal News - Zacks Investment Research
Biotech ETFs Surge on Biogen's Alzheimer Drug Approval - Yahoo Finance
After AstraZeneca, Oxford Nanopore Might Be The Next UK COVID Winner - Investing.com
Want to Use ETFs to Play Biotech? Choose Wisely. - Barron's
Unless Sorrento Makes Solid Progress Soon, It Will Likely Go Below $5 - Nasdaq
A Healthcare ETF Review: Biotech Beckons under Biden - ETF Trends
Medical Breakthrough ETFs for More than Just COVID - ETF Database
Virtus Lifesci Biotech Clinical Trials Etf (BBC) 財務データ
Virtus Lifesci Biotech Clinical Trials Etf (BBC) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
0.97%
大文字化:
|
ボリューム (24 時間):